These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34900069)

  • 21. Gut-Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension.
    Suswał K; Tomaszewski M; Romaniuk A; Świechowska-Starek P; Zygmunt W; Styczeń A; Romaniuk-Suswał M
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysbiosis of the gut and lung microbiome has a role in asthma.
    Hufnagl K; Pali-Schöll I; Roth-Walter F; Jensen-Jarolim E
    Semin Immunopathol; 2020 Feb; 42(1):75-93. PubMed ID: 32072252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiome a promising target for management of respiratory diseases.
    Trivedi R; Barve K
    Biochem J; 2020 Jul; 477(14):2679-2696. PubMed ID: 32726437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke.
    Singh V; Roth S; Llovera G; Sadler R; Garzetti D; Stecher B; Dichgans M; Liesz A
    J Neurosci; 2016 Jul; 36(28):7428-40. PubMed ID: 27413153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
    Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
    Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Horizontal transmission of gut microbiota attenuates mortality in lung fibrosis.
    Gurczynski SJ; Lipinski JH; Strauss J; Alam S; Huffnagle GB; Ranjan P; Kennedy LH; Moore BB; O'Dwyer DN
    JCI Insight; 2023 Nov; 9(1):. PubMed ID: 38015634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.
    De Nuccio F; Piscitelli P; Toraldo DM
    Lung; 2022 Dec; 200(6):773-781. PubMed ID: 36241745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases.
    Xu C; Hao M; Zai X; Song J; Huang Y; Gui S; Chen J
    Arch Microbiol; 2024 Feb; 206(3):107. PubMed ID: 38368569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.
    Wei L; Zhang L; Zhang Y; Yan L; Liu B; Cao Z; Zhao N; He X; Li L; Lu C
    J Ethnopharmacol; 2023 Sep; 313():116381. PubMed ID: 36940735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of gut microbiota to drug-induced liver injury.
    Chu HK; Ai Y; Cheng ZL; Yang L; Hou XH
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):458-465. PubMed ID: 37365109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases.
    Saint-Criq V; Lugo-Villarino G; Thomas M
    Ageing Res Rev; 2021 Mar; 66():101235. PubMed ID: 33321253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
    Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
    Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease.
    Zhou A; Lei Y; Tang L; Hu S; Yang M; Wu L; Yang S; Tang B
    J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33077630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiome effects on immunity, health and disease in the lung.
    Shukla SD; Budden KF; Neal R; Hansbro PM
    Clin Transl Immunology; 2017 Mar; 6(3):e133. PubMed ID: 28435675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
    Cheng J; Zhou L; Wang H
    Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbial dysbiosis occurring during pulmonary fungal infection in rats is linked to inflammation and depends on healthy microbiota composition.
    Popovic D; Kulas J; Tucovic D; Popov Aleksandrov A; Malesevic A; Glamoclija J; Brdaric E; Sokovic Bajic S; Golic N; Mirkov I; Tolinacki M
    Microbiol Spectr; 2023 Aug; 11(5):e0199023. PubMed ID: 37623316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet, Microbiota and Gut-Lung Connection.
    Anand S; Mande SS
    Front Microbiol; 2018; 9():2147. PubMed ID: 30283410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.